Loomis, Sayles & Company’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $6.95M | Hold |
|
|||||
|
2024
Q3 | $7.3M | Sell |
|
|||||
|
2024
Q2 | $7.39M | Hold |
|
|||||
|
2024
Q1 | $8.54M | Sell |
|
|||||
|
2023
Q4 | $88.9M | Buy |
|
|||||
|
2023
Q3 | $79.6M | Sell |
|
|||||
|
2023
Q2 | $108M | Sell |
|
|||||
|
2023
Q1 | $83.4M | Buy |
|
|||||
|
2022
Q4 | $67M | Sell |
|
|||||
|
2022
Q3 | $61.4M | Sell |
|
|||||
|
2022
Q2 | $74M | Sell |
|
|||||
|
2022
Q1 | $115M | Buy |
|
|||||
|
2021
Q4 | $105M | Buy |
|
|||||
|
2021
Q3 | $88.8M | Buy |
|
|||||
|
2021
Q2 | $93.2M | Buy |
|
|||||
|
2021
Q1 | $84.3M | Buy |
|
|||||
|
2020
Q4 | $33.1M | Buy |
|
|||||
|
2020
Q3 | $5.37M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $26.9M | Buy |
|
|||||
|
2019
Q4 | $46.7M | Sell |
|
|||||
|
2019
Q3 | $40.3M | Buy |
|
|||||
|
2019
Q2 | $31.8M | Buy |
|
|||||
|
2019
Q1 | $18.8M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $9K | Buy |
|